Translating Science into Novel Therapeutics
Staying true to our name (Sapience, noun: Wisdom), we seek to develop well pedigreed science into much needed medicine.
Addressing Cancer's Greatest Unmet Needs
Our lead candidate, ST101, is designed to promote cell death of hematologic malignancies and solid tumors, including acute myeloid leukemia (AML) and glioblastoma (GBM), two of the most deadly forms of cancer.
What makes ST101 Stand Out
Science Backed by Strong Leadership
Our world-class team is helping us pave the way to providing therapeutics for major unmet medical needs.
Promoting Tumor Cell Death
Our therapeutic candidates disrupt specific protein-protein interactions to directly and indirectly promote tumor cell death.